Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Ezallor Sprinkle, Crestor
Synonyms :
Class :
HMG-CoA Reductase Inhibitors
Brand Name :
Ezallor Sprinkle, Crestor
Synonyms :
Class :
HMG-CoA Reductase Inhibitors
Dosage Forms & Strengths
Tablet
5mg
10mg
20mg
40mg
Capsule
5mg
10mg
20mg
40mg
Dosage Forms & Strengths
Tablet
5mg
10mg
20mg
40mg
Capsule
5mg
10mg
20mg
40mg
Refer adult dosing
may increase the toxic effects of antibiotics
may enhance the serum concentration of simeprevir
may enhance the serum concentration of elbasvir/grazoprevir
may increase the myopathic effect of tafamidis
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
antacids reduce the concentration of rosuvastatin in the serum
antacids reduce the concentration of rosuvastatin in the serum
antacids reduce the concentration of rosuvastatin in the serum
antacids reduce the concentration of rosuvastatin in the serum
antacids reduce the concentration of rosuvastatin in the serum
may increase the toxic effects
may increase the toxic effects
may increase the toxic effects
may increase the toxic effects
may increase the toxic effects
may increase the hypoglycaemic effect
may increase the hypoglycaemic effect
may increase the hypoglycaemic effect
may increase the hypoglycaemic effect
may increase the hypoglycaemic effect
rosuvastatin: they may diminish the serum concentration of antacids
rosuvastatin: they may diminish the serum concentration of antacids
rosuvastatin: they may diminish the serum concentration of antacids
rosuvastatin: they may diminish the serum concentration of antacids
rosuvastatin: they may diminish the serum concentration of antacids
It may enhance the effect when combined with tafamidis meglumine
rosuvastatin: they may diminish the serum concentration of antacids
rosuvastatin: they may diminish the serum concentration of antacids
When rosuvastatin is used together with ouabain, this leads to reduction in rosuvastatin excretion
when both drugs are combined, there may be a decreased metabolism of etoposide
when both drugs are combined, there may be a decreased metabolism of vinblastine
Selective Serotonin Reuptake Inhibitors may enhance the hypoglycemic effect of Agents with Blood Glucose Lowering Effects
Selective Serotonin Reuptake Inhibitors may enhance the hypoglycemic effect of Agents with Blood Glucose Lowering Effects
Selective Serotonin Reuptake Inhibitors may enhance the hypoglycemic effect of Agents with Blood Glucose Lowering Effects
Selective Serotonin Reuptake Inhibitors may enhance the hypoglycemic effect of Agents with Blood Glucose Lowering Effects
Selective Serotonin Reuptake Inhibitors may enhance the hypoglycemic effect of Agents with Blood Glucose Lowering Effects
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
eltrombopag increases the concentration of rosuvastatin in the serum
may enhance the serum concentration of BRCP/ABCG2 inhibitors
aluminum hydroxide/magnesium hydroxide
may diminish the serum concentration of Antacids
niacin: they may increase the myopathic effect of rosuvastatin
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
ciprofibrate: it may enhance the serum concentration of HMG-CoA Reductase Inhibitors
darolutamide increases the concentration of rosuvastatin in the serum
Adverse drug reactions:
>10%
Myalgia
1-10%
Headache (3.1-8.5%)
Asthenia (0.9-6.3%)
Constipation (2.1-4.7%)
Arthralgia (10%)
Pharyngitis (9%)
Dizziness (4%)
Myalgia (7.6%)
Nausea (2.4-6.3%)
Abdominal pain (2%)
ALT increased (2%)
CPK increased (3%)
Diabetes mellitus (2.8%)
UTI (2%)
Arthralgia (3.8%)
Flulike illness (2%)
<1%
Myopathy
Jaundice
Rhabdomyolysis
Post marketing Reports
Peripheral neuropathy
Arthralgia
Pregnancy warnings:
AU TGA pregnancy category: D
US FDA pregnancy category: Not assigned
Lactation:
Excreted into human milk is known (amlodipine); Unknown (valsartan)
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: rosuvastatin
Why do we use rosuvastatin?
rosuvastatin are a Lipid-Lowering Agents, Statins, and HMG-CoA Reductase Inhibitors used to treat Familial Hypercholesterolemia and Hypercholesterolemia
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
